Clinical trial NCT06894537: Echo-guided Percutaneous Electrical Nerve Stimulation of the Femoral Nerve
Official title: Efficacy of Echo-guided Percutaneous Electrical Nerve Stimulation of the Femoral Nerve on Explosive Strength and Metabolic Response in Healthy Subjects. A Randomised Clinical Trial.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Health Subjects
Keywords: Percutaneous electrical nerve stimulation
Femoral nerve
Vertical jump
Skin temperature
Physiotherapy
Lead sponsor: Universidad Católica San Antonio de Murcia
Sponsor class: OTHER
First posted: 2025-03-25
Enrollment: 32
Sex: ALL
Minimum age (years): 18
Maximum age (years): 24
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: Introduction. Variables such as pain and strength can be modified in the short and medium term by the application of currents. The percutaneous form of percutaneous needle-guided acupuncture can eliminate the impedance of the surrounding tissues that limit the optimal diffusion of the current to the target tissue. It is necessary to objectify the metabolic response of this technique and its effects in terms of strength and metabolic response.

Objective. To evaluate the safety and efficacy, in acute and subacute phases, of percutaneous electrical nerve stimulation in healthy subjects.

Method. Single-blind randomised clinical study. Thirty-two subjects will be recruited and randomised to the experimental and control groups. The intervention in the experimental group will consist of a percutaneous percutaneous electrical nerve stimulation of the femoral nerve, while in the control group the same intervention will be performed without increasing the intensity of the current. The primary variable will be vertical jump height (My Jump® iOS app) and the secondary variable will be skin temperature (Hikmicro M60 model Hangzhou).


Eligibility criteria: Inclusion Criteria:

* Persons aged 18 and 24.
* Of both sexes.
* Who practice sport at least twice a week.
* Who sign the informed consent document.

Exclusion Criteria:

* Medical diagnosis of chronic systemic diseases or diseases that may interfere with thermographic imaging (rheumatoid arthritis, fibromyalgia, deep vein thrombosis, etc.).
* Having undergone lower limb surgery in the 24 months prior to the study.
* Intake of drugs that may influence the thermographic response (antipyretics, non-steroidal anti-inflammatory drugs, topical solutions on the area to be studied, etc.).
* People with nickel allergy or belonephobia (needle phobia).

Primary outcomes:
measure: Change from baseline jump height after warming, treatment and at 1 and 24 hours
timeFrame: Baseline, within the first seven days after warming, treatment and after 1 and 24 hours follow-up visit
Secondary outcomes:
measure: Change from baseline muscle power after warming, treatment and at 1 and 24 hours
timeFrame: Baseline, within the first seven days after warming, treatment and after 1 and 24 hours follow-up visit
Other outcomes:
Locations:
city: Murcia
country: Spain
facility: Universidad Católica San Antonio de Murcia
state: Asturias
Study officials:
References: